Bone disorders in chronic liver diseases (Q37811999)

23 August 2017

Bone disorders in chronic liver diseases (English)

1 reference

23 August 2017

chronic liver disease

0 references

author name string

Bruce A Luxon

series ordinal

1

1 reference

23 August 2017

1 February 2011

1 reference

Current gastroenterology reports

23 August 2017

1 reference

23 August 2017

13

1 reference

23 August 2017

40-48

1 reference

23 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-010-0166-4

23 August 2017

0 references

cites work

Potential nonclassical effects of vitamin D in transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Vitamin D replacement for cirrhosis-related bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

AGA technical review on osteoporosis in hepatic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Low bone turnover state in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Current understanding of osteoporosis associated with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Bone disorders in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Bone fractures in liver transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Calcitriol for bone loss in patients with primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Deranged bone mineral metabolism in chronic alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Is alcohol an osteoporosis-inducing agent for young and middle-aged women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Bone mineral density before and after OLT: long-term follow-up and predictive factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Prevalence and prediction of osteopenia in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Fracture Risk in People With Primary Biliary Cirrhosis: A Population-Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0166-4

Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis

21 January 2018

1 reference

12 December 2020

Bone mineral density among cirrhotic patients awaiting liver transplantation

1 reference

12 December 2020

Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis

1 reference

12 December 2020

Guidelines on the management of osteoporosis associated with chronic liver disease

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?

1 reference

12 December 2020

High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation

1 reference

12 December 2020

Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids

1 reference

12 December 2020

Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis?

1 reference

12 December 2020

The prevention of bone fractures after liver transplantation: experience with alendronate treatment

1 reference

12 December 2020

Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors

1 reference

12 December 2020

Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload

1 reference

12 December 2020

Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis

1 reference

12 December 2020

Vertebral fractures and osteopenia in chronic alcoholic patients

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment

1 reference

12 December 2020

Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years

1 reference

12 December 2020

Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis

1 reference

12 December 2020

Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis

1 reference

12 December 2020

Metabolic bone disease in primary biliary cirrhosis at presentation

1 reference

12 December 2020

Bone mineral density in men with genetic hemochromatosis and HFE gene mutation

1 reference

12 December 2020

Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease

1 reference

12 December 2020

Factors influencing the development of metabolic bone disease in primary biliary cirrhosis

1 reference

12 December 2020

Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis

1 reference

12 December 2020

Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study

1 reference

12 December 2020

Treatment of bone disorders in liver disease

1 reference

12 December 2020

10.1007/S11894-010-0166-4

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21104208